5AM Venture Management, LLC
SAN FRANCISCO, CA · CIK 1799883 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2021 · limited liability company
- Assets managed$1.1bn
- Staff32 · 18 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds12 (1 hedge) · $947.0m gross assets
- Website5amventures.com
- Form ADV · 2026-03-30SEC adviser record
- Kindhedge funds, private equity, venture, futures
- Others nearbySan Francisco, CA, Boston, MA, New York, NY
As an employer
- Offices in1 country
- Private fundsventure capital 9, private equity 2, hedge 1
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| San Francisco, CA (main office)United States | about 8 |
| Boston, MAUnited States | 7 |
| New York, NYUnited States | 3 |
US visa salary filings
- Filings FY20251
- Median salary offered$350,000
- Middle half$350,000 – $350,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior Research AnalystNew York, NY | 1 | $350,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: 5AM Venture Management, LLC.
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| SKYE BIOSCIENCE INC COM NEW | $41.4m15.93% | Unchanged |
| ENTRADA THERAPEUTICS INC TRDA | $29.0m11.13% | Reduced -100.0k |
| DIANTHUS THERAPEUTICS INC DNTH | $18.3m7.05% | Reduced -43.0k |
| ENLIVEN THERAPEUTICS INC ELVN | $15.5m5.96% | Reduced -550.0k |
| PHARVARIS N V PHVS | $14.0m5.40% | Unchanged |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $13.3m5.12% | Unchanged |
| CENTESSA PHARMACEUTICALS PLC SPONSORED ADS | $10.9m4.20% | Unchanged |
| VOR BIOPHARMA INC COM | $10.3m3.96% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $10.3m3.96% | Unchanged |
| TECTONIC THERAPEUTIC INC TECX | $10.2m3.91% | Unchanged |
| CELLDEX THERAPEUTICS INC NEW CLDX | $10.1m3.89% | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT | $9.9m3.80% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $9.0m3.46% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $7.1m2.75% | Unchanged |
| GH RESEARCH PLC GHRS | $7.0m2.68% | Unchanged |
| ERASCA INC ERAS | $6.9m2.64% | Unchanged |
| BIOHAVEN LTD BHVN | $6.8m2.60% | Unchanged |
| VIKING THERAPEUTICS INC VKTX | $5.0m1.93% | Unchanged |
| SCPHARMACEUTICALS INC SCPH | $4.6m1.76% | Unchanged |
| CAMP4 THERAPEUTICS CORP CAMP | $4.2m1.63% | Unchanged |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $3.6m1.37% | Unchanged |
| SURROZEN INC SRZN | $2.8m1.07% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $2.8m1.06% | Unchanged |
| PROTARA THERAPEUTICS INC TARA | $2.4m0.93% | Unchanged |
| ALECTOR INC ALEC | $1.4m0.54% | Unchanged |
| RALLYBIO CORP COM | $1.2m0.47% | Unchanged |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $1.2m0.45% | Unchanged |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $568.4k0.22% | Unchanged |
| MERSANA THERAPEUTICS INC COM | $386.3k0.15% | Unchanged |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| ANAPTYSBIO INC ANAB | $6.7m357.7k shares |
| CIDARA THERAPEUTICS INC CDTX | $1.2m56.7k shares |